Overview
International Symposium on Left Atrial Appendage 2020
ISLAA
Registration is closed for this activity.
This symposium is designed for physicians, nurses, and allied health professionals in the fields of electrophysiology, cardiology, cardiothoracic surgery, neurology, family and internal medicine.
This symposium is a multi-specialty cardiovascular educational symposium in North America on the frontier science of left atrial appendage. This topic is of tremendous interest in the practice of cardiovascular care. Over a period of two days, the symposium will offer very informative presentations on the anatomy, physiology and pathological aspects of the left atrial appendage along with old and new therapeutic strategies of stroke prophylaxis including cardiac devices for LAA exclusion. Presenting will be the leaders in the field with a great depth of practical expertise in the science from all across the world.
Upon completion of this activity, participants will be able to:
• Compare and contrast NOACs for efficacy and safety, while emphasizing the patient populations for whom they are best suited.
• Review evidence-based guidelines and best clinical approaches to thromboprophylaxis.
• Assess the cost-effectiveness of systemic anticoagulation versus LAA exclusion technologies for stroke prophylaxis.
• Review the role of oral anticoagulation in stroke prophylaxis.
• Describe systemic thromboembolization and the role of LAA in patients with atrial fibrillation.
• Express a working knowledge of the role of the LAA in atrial arrhythmias origin and maintenance.
• Discuss treatment options for the management of postoperative pericardial inflammation.
• Identify needle devices which can be utilized in specific patients to minimize complications associated with epicardial access.
• Review device types and techniques which may be employed to mitigate an incomplete LAA closure.
• Compare and contrast NOACs for efficacy and safety, while emphasizing the patient populations for whom they are best suited.
• Review evidence-based guidelines and best clinical approaches to thromboprophylaxis.
• Assess the cost-effectiveness of systemic anticoagulation versus LAA exclusion technologies for stroke prophylaxis.
• Review the role of oral anticoagulation in stroke prophylaxis.
• Describe systemic thromboembolization and the role of LAA in patients with atrial fibrillation.
• Express a working knowledge of the role of the LAA in atrial arrhythmias origin and maintenance.
• Discuss treatment options for the management of postoperative pericardial inflammation.
• Identify needle devices which can be utilized in specific patients to minimize complications associated with epicardial access.
• Review device types and techniques which may be employed to mitigate an incomplete LAA closure.
New York Marriott Marquis
1535 Broadway
New York, NY 10036 USA
Click here to view location map
Phone: 212-398-1900
1535 Broadway
New York, NY 10036 USA
Click here to view location map
Phone: 212-398-1900
For additional details, please visit the conference website at www.islaasymposium.com/.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and ISLAA Foundation. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
*The Academy for Continued Healthcare Learning designates this live activity for a maximum of 17.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider Number 17273 for 17.50 contact hours.
*Credit based on previous year agenda. Subject to change.